This federal contract award is for the delivery of OPZELURA 1.5% Cream 60GM to the Defense Logistics Agency (DLA), a defense agency. The $1,250.23 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 19, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of OPZELURA 1.5% cream (60g) to the Defense Logistics Agency (DLA). The $6,153.92 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024, with a completion date of July 25, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical to...
This federal contract award is for the delivery of OPZELURA 1.5% CREAM 60GM to the Defense Logistics Agency (DLA). The $3,501.18 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024. The contract has an ultimate completion date of October 31, 2024 and is a delivery order. This award is a child contract under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price ceiling value of $5,395.50 and a completion date of February 1, 2024. The contract was awarded through full and open competition, with no set-aside designation....
This federal contract award is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,761.57, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of OPZELURA 1.5% CREAM 60GM to the Defense Logistics Agency (DLA). The $2,739.03 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 27, 2023. The contract has an ultimate completion date of September 28, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
This federal contract award is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,165.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024, with a completion date of November 21, 2024. The contract is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of OPZELURA 1.5% cream in 60 gram units. The $2,575.62 firm fixed price order was placed by the Defense Logistics Agency (DLA) Troop Support Medical division and is expected to be completed by February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not designated as a set-aside...
This federal contract award, valued at $1,845.78, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a Delivery Order for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with an ultimate completion date of October 10, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This federal contract award, valued at $2,620.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...